Here are Top Health stories of the day
2 Doctors face Medical Council Inquiry for allegedly issuing fake life certificates to dead persons-
The Tamil Nadu Medical Council (TNMC) has recently issued notices to two doctors for allegedly issuing fake "life certificates" of people who had died earlier.
One of the two doctors is serving as an Assistant Surgeon with the Royapettah Government Hospital, Chennai, whereas the other doctor runs a private clinic in Hosur.
For more details, check out the full story on the link below:
2 Doctors Face Medical Council Inquiry For Allegedly Issuing Fake Life Certificates To Dead Persons
Manipur gets its first Private Medical College with 150 MBBS seats
In a major milestone for medical education in Manipur and North-East India, the National Medical Commission (NMC) has given its nod for setting up the first private medical college in Imphal. The college has received permission from NMC for admitting 150 MBBS students from the academic session 2021-2022.
The confirmation in this regard has come from the Chairman & Managing Director of Shija Hospitals and Research Institute (SHRI), Dr. Palin Khundongbam, while he was addressing a press conference on Sunday. Director (SAHS) Dr. M Amuba, Board of directors (SAHS) Dr. Jugindra Sorokhaibam, Bonney Devi S and Gayatri Maibam, and Medical Superintendent (SAHS) Kaushik Debnath also attended the press conference.
For more details, check out the full story on the link below:
Manipur Gets Its First Private Medical College With 150 MBBS Seats
NMC gives nod to MD Radiation Oncology course at Baroda Medical College
The Medical College, Baroda, will be introducing a new post-graduate course in radiation oncology since it has received the approval from the National Medical Commission (NMC).
Radiation oncology is a sub-speciality of oncology. It is basically to treat cancer through radiation therapy.
For more details, check out the full story on the link below:
NMC Gives Nod To MD Radiation Oncology Course At Baroda Medical College
Lupin, Sun Pharma recall Loratadine-D, Gatifloxacin in US
Leading drug makers Sun Pharma and Lupin are recalling different products in the US, the world's largest market for medicines, for different reasons.
As per the latest enforcement report by the US Food and Drug Administration (USFDA), Sun Pharma is recalling 22,752 blister packs of Loratadine-D extended-release tablets, used for the treatment of allergic rhinitis and the common cold, in the US market.
For more details, check out the full story on the link below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.